Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
1h
Alnylam Pharma’s Regulatory Challenges and Market Uncertainty Lead to Hold Rating
Leerink Partners analyst Mani Foroohar has maintained their neutral stance on ALNY stock, giving a Hold rating on November 25.Don't Miss our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Cabinet OKs ceasefire deal
US Navy plane shadowed
US forces strike in Syria
‘Forbidden Planet' star dies
To attend inauguration
Selected as Trump’s USTR
Bhattacharya to lead NIH
Thanksgiving storm forecast
Subway CEO to step down
Lester fit to stand trial
Alleged impropriety probe
Tilson to run for NYC mayor
Court to end docs case
Transition agreement signed
Stolen gold coins recovered
Fugitive arrested in UK
Senate report slams airlines
Mutual HIV transplants rule
North Carolina fires coach
To testify on AFG withdrawal
Visiting border with Abbott
US new home sales tumble
MO trans care ban upheld
Man sentenced for threats
Consumer confidence rises
International Emmys winners
Rays stadium deal deadline
Accuses judge in assets case
Charge dismissal appealed
Tapped to be Navy secretary
Former FBI informant indicted
Related topics
FDA
BridgeBio
Food and Drug Administration
Alnylam
Pfizer
Feedback